Entera Bio Ltd. (ENTX)

Entera Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	11.02	12.31	24.89	8.59	15.19
Cash & Cash Equivalents	11.02	12.31	24.89	8.59	15.19
Cash Growth	-10.48%	-50.55%	189.68%	-43.41%	31.80%
Receivables	0	0.25	0.18	0.26	0.28
Other Current Assets	0.24	0.29	0.25	0.26	0.17
Total Current Assets	11.26	12.85	25.33	9.11	15.64
Property, Plant & Equipment	0.49	0.23	0.4	0.57	0.46
Goodwill and Intangibles	0	0	0	0	0.61
Other Long-Term Assets	0.02	0.05	0.26	0.05	0
Total Long-Term Assets	0.51	0.28	0.66	0.61	1.07
Total Assets	11.77	13.13	25.99	9.72	16.7
Accounts Payable	0.08	0.02	0.17	0.16	0.33
Deferred Revenue	0	0	0.02	0.16	0.27
Current Debt	0.13	0.09	0.18	0.19	0.18
Other Current Liabilities	0.87	1.23	2.8	1.33	3.81
Total Current Liabilities	1.09	1.34	3.16	1.84	4.59
Long-Term Debt	0.26	0	0.12	0.24	0.12
Other Long-Term Liabilities	0.03	0.03	0.14	0.13	0.07
Total Long-Term Liabilities	0.29	0.03	0.26	0.37	0.19
Total Liabilities	1.38	1.37	3.42	2.21	4.78
Total Debt	0.39	0.09	0.3	0.43	0.3
Debt Growth	328.57%	-69.87%	-30.09%	44.48%	-
Retained Earnings	-104.39	-95.5	-82.43	-70.24	-62.91
Comprehensive Income	0.04	0.04	0.04	0.04	0.04
Shareholders' Equity	10.39	11.75	22.57	7.51	11.92
Net Cash / Debt	10.63	12.22	24.59	8.16	14.89
Net Cash / Debt Growth	-13.01%	-50.31%	201.31%	-45.18%	29.21%
Net Cash Per Share	0.37	0.42	0.94	0.44	1.23
Working Capital	10.17	11.51	22.17	7.27	11.04
Book Value Per Share	0.36	0.41	0.86	0.41	0.98

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).